Understanding obesity drug treatments
Part of Hormones & metabolism clinical trials.
This study aims to better understand patients who are prescribed medications like Orlistat, Mysimba, Saxenda, Wegovy, or Mounjaro for obesity. It will help doctors improve treatments for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 years or older.
- Your doctor must have prescribed one of these obesity drugs: Orlistat, Mysimba, Saxenda, Wegovy, or Mounjaro.
- You cannot have type 1 or type 2 diabetes.
- Your obesity cannot be caused by certain rare conditions (like Prader-Willi syndrome) or untreated thyroid problems.
- You cannot have obesity from pituitary or hormone issues like Cushing's syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how obesity treatments work in real life for adults with a high body mass index. It aims to help doctors understand what works best for different people.
This study tracks how your eating behavior changes when you take obesity medication. Researchers want to understand what happens to your appetite and food choices before, during, and after treatment to help improve how these medications work.
This study tests a simple cheek swab that may help doctors pick the most effective weight-loss medication for each person. Participation could help tailor your treatment, potentially improving results.
This study looks at how people lose weight after medication or surgery for obesity. It helps predict which treatment might work best for you.
This study tests whether a medication called semaglutide, which is used for weight loss, works better for people who also have binge eating. It aims to find the best treatment based on brain and behavior differences.
This study looks at how anti-obesity medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) affect your muscles and movement. It may help researchers understand how to combine these drugs with exercise for better health.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.